No. HT942526RCRPCA · Defense Health Agency Contracting Activity - DHACA
DoW Rare Cancers Concept Award
Not reimbursement-only
“The funding instrument for awards made under the program announcement will be grants (31 USC 6304).” — From the announcement
- Award range
- Not specified
- Expected awards
- ~18
- Application deadline
- Sep 30, 2026 28 days left
- Posted
- Jun 17, 2026
- Last verified
- 3 days ago
At a glance
AI summaryThe FY26 Rare Cancers Concept Award funds highly innovative, untested ideas in rare cancers and does not allow clinical trials. Eligible applicants include U.S. Department of War intramural and extramural organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; the PI must be an independent investigator at or above postdoctoral level and may be named on only one application. The program expects about $2.52 million to fund about 18 awards, with a total cost cap of $140,000 per award and a 2-year maximum period of performance; cost sharing is not required. The research must relate to rare cancers affecting six or fewer people per 100,000 per year in the United States and be relevant to active-duty Service Members, Veterans, military beneficiaries, and the American public.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel course of investigation in the field of rare cancers. Distinctive Features: Preliminary data are not required. Due to the blinded nature of the review process, identifying or making references to the Principal Investigator (PI), collaborator(s), or their organization(s) in the proposal Project Narrative, Supporting Documentations, Impact Statement, Justification Statement, and Statement of Work (SOW) is prohibited and will result in administrative rejection of the application.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026